World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

Cefazolin Prophylaxis in Children Undergoing Cardiac Surgery with the Use of Cardiopulmonary Bypass-Is the Dosing Correct?

Pediatric Zone, Perfusion Devices, Perfusion Zone, Tiny Perfusion Letter

1 min read

Luc Puis

You may also like

New Technologies

Nanotechnology in Medicine

Nanotechnology has wide applications in the medical field in the form of nanomedicine. Some nanoparticles have potential applications in new diagnostic devices, imaging and methodologies, targeted medicines, pharmaceuticals, biomedical implants, and tissue engineering.

1 min read

Blood Management, Main Zone, Mobile Zone, Perfusion Zone

Use of Recombinant Activated Factor VII for Controlling Refractory Postoperative Bleeding in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

To review the efficacy, safety, and dose of recombinant activated factor VII in off-label management of refractory bleeding in pediatric patients with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass.

1 min read

Blood Management, Perfusion Devices, Perfusion Zone, Tiny Perfusion Letter

Evaluation of the Impact of HMS Plus on Postoperative Blood Loss Compared with ACT Plus in Cardiac Surgery

HMS Plus did not reduce the mean blood-loss volume during the first 24 postoperative hours compared with ACT Plus. Its utility for potential transfusion rate reduction remains to be proven.

1 min read